Dr. Arendash served as a Full Professor and Research Professor at the University of South Florida for 30 years. During his final six years there, he directed the Florida Alzheimer’s Disease Research Center’s Animal Core and one of its three principal research initiatives. Specializing in the development of Alzheimer's disease therapeutics, Dr. Arendash has published over 120 peer-reviewed articles in first-tier journals, such as Science, Nature, and the Journal of Alzheimer’s Disease, where he served as Senior Editor until 2017. During his tenure at USF, he secured $5 million in research funding from external agencies, including the National Institutes of Health (NIH) and the Alzheimer’s Disease and Related Disorders Association (ADRDA). Dr. Arendash was among the pioneers to demonstrate that Alzheimer's Disease begins in the brain decades before its clinical diagnosis. His landmark study in 2010 provided initial evidence that electromagnetic treatment induces cognitive benefits in Alzheimer's mice through multiple disease-modifying mechanisms. He further advanced this promising pre-clinical research by conducting three clinical studies from 2019 to 2023, which demonstrated the safety and efficacy of the technology he developed against Alzheimer’s. Dr. Arendash received his doctorate in Neuroscience/Physiology from the University of California, San Francisco (UCSF) and completed his post-doctoral research at UCLA’s Brain Research Institute before joining the University of South Florida faculty.

LinkedIn Profile